-+ 0.00%
-+ 0.00%
-+ 0.00%

William Blair Initiates Coverage On BridgeBio Pharma with Outperform Rating

Benzinga·03/10/2026 13:51:31
Listen to the news
William Blair analyst John Boylan initiates coverage on BridgeBio Pharma (NASDAQ:BBIO) with a Outperform rating.